Related Experiment Video
Updated: Aug 18, 2026
Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
Published on: July 12, 2024
Clinical implications of an accurate problem list on heart failure treatment
Daniel M Hartung1, Jacquelyn Hunt, Joseph Siemienczuk
1Oregon State University College of Pharmacy, Portland, OR, USA.
Insights
Accurate heart failure documentation on patient problem lists increases the likelihood of prescribing evidence-based medications for systolic dysfunction. This improves patient care by ensuring guideline-directed therapy is administered.
Area of Science:
- Cardiology
- Health Informatics
- Clinical Pharmacy
Background:
- Problem-oriented medical records aim for improved patient care through accurate problem lists.
- Empirical evidence linking structured problem lists to better patient outcomes is limited.
- The study addresses the gap in understanding the impact of problem list accuracy on treatment adherence.
Purpose of the Study:
- To evaluate the association between heart failure documentation on problem lists and the prescription of evidence-based pharmacotherapy.
- To determine if accurate problem list entries influence the prescribing of medications for systolic dysfunction.
Main Methods:
- A cross-sectional study was conducted in community-based primary care clinics.
- The study included active patients with left ventricular ejection fraction ≤40%, with or without a heart failure diagnosis.
- The primary outcome measured was the proportion of patients prescribed medications with known benefits for systolic dysfunction.
Main Results:
- Patients with heart failure documented on their problem list were more likely to receive angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (92.2% vs. 76.7%).
- Accurate problem list documentation was also associated with increased use of digoxin (61.1% vs. 36.7%) and spironolactone (26.7% vs. 13.3%).
- No significant difference in beta-blocker prescription rates was observed between groups.
Conclusions:
- Accurate heart failure documentation on patient problem lists is significantly associated with increased prescription of beneficial medications for systolic dysfunction.
- This finding supports the importance of precise problem list management in ensuring guideline-directed medical therapy.
- Improved problem list accuracy can enhance the delivery of evidence-based pharmacotherapy for patients with heart failure.
Context:
The premise of the problem-oriented medical record is that an accurately defined problem list will directly result in more thorough and efficient patient care. However, little empirical evidence exists demonstrating improved patient outcomes as a result of an adequately structured problem list.
Objective:
To determine the impact of problem list documentation of heart failure on the likelihood that evidence-based pharmacotherapy has been prescribed.
Design:
Cross-sectional study.
Setting:
Community-based primary care clinics in Portland, Oregon.
Subjects:
Active patients in the network with a left ventricular ejection fraction of 40% or less, with and without heart failure, in their structured problem list.
Main Outcome Measures:
The proportion of patients prescribed medications with known benefits for systolic dysfunction.
Results:
In this group of patients with known systolic dysfunction, the likelihood of therapy with either an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker was higher in patients who had heart failure listed on their problem list compared to patients who did not (92.2% vs 76.7%; P<.05). This association remained after statistical adjustment for age, gender, and ejection fraction. Patients with accurate problem list entries were also more likely to receive digoxin (61.1% vs 36.7%; P=.001) and spironolactone (26.7% vs 13.3%; P=.025). There were no differences in the use of beta-blockers between the 2 groups.
Conclusion:
Accurate documentation of heart failure on the problem list of patients with known systolic dysfunction is associated with a significant increase in the likelihood of being prescribed medications with known clinical benefit.
Related Concept Videos
01:30Heart Failure VII: Nursing Interventions
01:22Heart Failure VI: Adjunct Therapies
01:30Heart Failure IV: Classification and Diagnostic Evaluation
01:30Heart Failure V: Medical Management
01:17Pathophysiology of Heart Failure
01:27Heart Failure I: Introduction